Michael Thomas Henderson Apogee Therapeutics, Inc. (APGE) insider trading activity

APGE Quotes by TradingView
Shares Held (Direct Ownership) 1.35M
8.14% 3M change
n/a 12M change
Total Value Held N/A

MICHAEL THOMAS HENDERSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 02 2024
SELL
Open market or private sale
$2,256,400 $56.41 p/Share
40,000 Reduced 2.87%
1,354,487 Common Stock
Sep 04 2024
SELL
Open market or private sale
$1,910,000 $47.75 p/Share
40,000 Reduced 2.79%
1,394,487 Common Stock
Aug 07 2024
SELL
Open market or private sale
$1,654,400 $41.36 p/Share
40,000 Reduced 2.71%
1,434,487 Common Stock
Jul 05 2024
SELL
Open market or private sale
$558,900 $37.26 p/Share
15,000 Reduced 1.01%
1,474,487 Common Stock

Also insider at

BBIO
BridgeBio Pharma, Inc. Healthcare
Chief Business Officer
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
ARYD
ARYA Sciences Acquisition Corp IV Financial Services
MTH

Michael Thomas Henderson

Chief Executive Officer
Palo Alto, CA

Track Institutional and Insider Activities on APGE

Follow Apogee Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APGE shares.

Notify only if

Insider Trading

Get notified when an Apogee Therapeutics, Inc. insider buys or sells APGE shares.

Notify only if

News

Receive news related to Apogee Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APGE